Loading clinical trials...
Loading clinical trials...
Observational Study of Tofacitinib in Ulcerative Colitis in Sweden (ODEN)
Conditions
Interventions
tofacitinib
Locations
17
Sweden
Ulf Eriksson
Alingsås, Sweden
Medicinkliniken, Södra Älvsborgs Sjukhus Borås, Brämhultsvägen 53
Borås, Sweden
Gävle Hospital
Gävle, Sweden
SU/Sahlgrenska, Gastroenterologi & Hepatologi
Gothenburg, Sweden
Medicinkliniken, Länssjukhuset Ryhov, Sjukhusgatan
Jönköping, Sweden
Daniel Molin
Kristianstad, Sweden
Start Date
September 14, 2020
Primary Completion Date
March 30, 2026
Completion Date
March 30, 2026
Last Updated
March 13, 2026
NCT07550673
NCT05739864
NCT07271069
NCT06975722
NCT07185009
NCT07184996
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions